Nasdaq:US$19.28 (+0.50) | HKEX:HK$30.20 (+0.30) | AIM:£3.05 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 23 Dec 2014

Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1,2,3 tyrosine kinases for cancer therapy (Cancer Biology & Therapy 2014)